Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.418
Delayed Data
As of Feb 24
 -0.0087 / -2.04%
Today’s Change
0.36
Today|||52-Week Range
3.66
+12.31%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close0.43
Today’s open0.42
Day’s range0.41 - 0.43
Volume704,814
Average volume (3 months)1,284,065
Market cap$48.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
CURNeuralstem Inc+0.16+4.32%
VSTMVerastem Inc-0.07-5.70%
CLBSCaladrius Bioscience...-0.20-3.81%
MTFBMotif Bio PLC-0.03-0.47%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Operating &
Medical Officer
Daniel J. Levitt
Corporate headquarters
Los Angeles, California

Forecasts


Search for Jobs